Home / COR-NTD / NTD ConnectOR / Using Geostatistical Tools to Develop a Stop MDA Survey for LF Triple Drug...

Using Geostatistical Tools to Develop a Stop MDA Survey for LF Triple Drug Therapy

Can geostatistical tools be used to develop a stop IDA strategy for LF that can measure <1% Mf prevalence in adults?

Sites

Implementation partner(s): Kenya | India | PNG | Samoa | American Samoa
WHO Region: EURO

Notes

This strategy will employ model-based geostatistics (MBG), as outlined in the paper by Fronterre et al, "Design and Analysis of Elimination Surveys for Neglected Tropical Diseases". J Infect Dis. 2020 Jun 11;221(Supplement_5):S554-S560. doi: 10.1093/infdis/jiz554.

 

Email primary contact

Please log in or register